Cargando…
Development of a Rapid In Vitro Screening Assay Using Metabolic Inhibitors to Detect Highly Selective Anticancer Agents
[Image: see text] Traditional long exposure (24–72 h) cell viability assays for identification of potential drug compounds can fail to identify compounds that are: (a) biologically active but not toxic and (b) inactive without the addition of a synergistic additive. Herein, we report the development...
Autores principales: | Abebe, Felagot A., Hopkins, Megan D., Vodnala, Suraj N., Sheaff, Robert J., Lamar, Angus A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296616/ https://www.ncbi.nlm.nih.gov/pubmed/34308064 http://dx.doi.org/10.1021/acsomega.1c02203 |
Ejemplares similares
-
Synthesis and in vitro assay of hydroxyxanthones as antioxidant and anticancer agents
por: Fatmasari, Nela, et al.
Publicado: (2022) -
Immune cell-based screening assay for response to anticancer agents: applications in pharmacogenomics
por: Frick, Amber, et al.
Publicado: (2015) -
Discovery of New Glucose Uptake Inhibitors as Potential Anticancer Agents by Non-Radioactive Cell-Based Assays
por: Hung, Hsueh-Chih, et al.
Publicado: (2022) -
The Comparison of MTT and CVS Assays for the Assessment of Anticancer Agent Interactions
por: Śliwka, Lidia, et al.
Publicado: (2016) -
Visible-Light, Iodine-Promoted Formation of N-Sulfonyl Imines and N-Alkylsulfonamides from Aldehydes and Hypervalent Iodine Reagents
por: Hopkins, Megan D., et al.
Publicado: (2018)